179 related articles for article (PubMed ID: 22456267)
21. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
23. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
Wang DG; Johnston CF; Buchanan KD
Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R; Libutti SK; Saif MW
JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
[TBL] [Abstract][Full Text] [Related]
25. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
26. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
[TBL] [Abstract][Full Text] [Related]
27. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
Arnold CN; Sosnowski A; Blum HE
Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
[TBL] [Abstract][Full Text] [Related]
28. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
Stevenson M; Lines KE; Thakker RV
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):525-548. PubMed ID: 30098714
[TBL] [Abstract][Full Text] [Related]
29. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
Gupta S; Engstrom PF; Cohen SJ
Clin Colorectal Cancer; 2011 Dec; 10(4):298-309. PubMed ID: 21813338
[TBL] [Abstract][Full Text] [Related]
30. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
31. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
[TBL] [Abstract][Full Text] [Related]
32. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
[No Abstract] [Full Text] [Related]
33. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
Gloesenkamp C; Nitzsche B; Lim AR; Normant E; Vosburgh E; Schrader M; Ocker M; Scherübl H; Höpfner M
Int J Oncol; 2012 May; 40(5):1659-67. PubMed ID: 22246317
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
35. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
[TBL] [Abstract][Full Text] [Related]
36. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
[No Abstract] [Full Text] [Related]
37. Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
Lubensky IA; Zhuang Z
Endocr Pathol; 2007; 18(3):156-62. PubMed ID: 18041590
[TBL] [Abstract][Full Text] [Related]
38. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 in human neuroendocrine: tumorigenesis.
Chung DC
Ann N Y Acad Sci; 2004 Apr; 1014():209-17. PubMed ID: 15153436
[TBL] [Abstract][Full Text] [Related]
40. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]